Literature DB >> 29103403

Emergence of the L phenotype in Group B Streptococci in the South of Ireland.

K Hayes1, L Cotter1, L Barry2, F O'Halloran1.   

Abstract

Group B Streptococcal isolates (n = 235) from the South of Ireland were characterised by serotyping, antimicrobial susceptibility and determination of the phenotypic and genotypic mechanisms of resistance. Resistance to erythromycin and clindamycin was observed in 21·3% and 20·4% of the total population, respectively. The c-MLSB phenotype was the most common phenotype detected (62%), with ermB being the predominant genetic determinant, present in 84% of resistant isolates. The rare L phenotype was observed in 2·9% (n = 7) of isolates, four of which harboured the lsaC gene responsible for clindamycin resistance. Serotypes Ia, III and II were the most common amongst the entire study population (28·1%, 24·7% and 14%, respectively). Four of the seven L phenotype isolates were serotype III and two of these strains were confirmed as the hypervirulent clone, ST-17 and harboured the hvgA gene. This is the first documented case of the L phenotype in Ireland to date and the study findings emphasise the need for continued monitoring of antibiotic resistance and serotype distribution in GBS isolates from Ireland.

Entities:  

Keywords:  Microbiology; Streptococcal infections; antibiotic resistance; surveillance

Mesh:

Substances:

Year:  2017        PMID: 29103403      PMCID: PMC9148724          DOI: 10.1017/S0950268817002461

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  39 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci.

Authors:  Claire Poyart; Asmaa Tazi; Hélène Réglier-Poupet; Annick Billoët; Nicole Tavares; Josette Raymond; Patrick Trieu-Cuot
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

Review 3.  Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.

Authors:  Karen M Edmond; Christina Kortsalioudaki; Susana Scott; Stephanie J Schrag; Anita K M Zaidi; Simon Cousens; Paul T Heath
Journal:  Lancet       Date:  2012-01-04       Impact factor: 79.321

4.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

6.  The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates.

Authors:  Asmaa Tazi; Olivier Disson; Samuel Bellais; Abdelouhab Bouaboud; Nicolas Dmytruk; Shaynoor Dramsi; Michel-Yves Mistou; Huot Khun; Charlotte Mechler; Isabelle Tardieux; Patrick Trieu-Cuot; Marc Lecuit; Claire Poyart
Journal:  J Exp Med       Date:  2010-10-18       Impact factor: 14.307

7.  Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.

Authors:  Samuel Bellais; Anne Six; Agnès Fouet; Magalie Longo; Nicolas Dmytruk; Philippe Glaser; Patrick Trieu-Cuot; Claire Poyart
Journal:  J Infect Dis       Date:  2012-09-21       Impact factor: 5.226

8.  Host specificity in the diversity and transfer of lsa resistance genes in group B Streptococcus.

Authors:  Pierre-Emmanuel Douarre; Elisabeth Sauvage; Claire Poyart; Philippe Glaser
Journal:  J Antimicrob Chemother       Date:  2015-09-25       Impact factor: 5.790

9.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

10.  Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa.

Authors:  Sabine Belard; Nicole Toepfner; Mesküre Capan-Melser; Ghyslain Mombo-Ngoma; Rella Zoleko-Manego; Mirjam Groger; Pierre-Blaise Matsiegui; Selidji T Agnandji; Ayôla A Adegnika; Raquel González; Peter G Kremsner; Clara Menendez; Michael Ramharter; Reinhard Berner
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

View more
  2 in total

Review 1.  Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.

Authors:  Fiorella Bianchi-Jassir; Proma Paul; Ka-Ning To; Clara Carreras-Abad; Anna C Seale; Elita Jauneikaite; Shabir A Madhi; Neal J Russell; Jenny Hall; Lola Madrid; Quique Bassat; Gaurav Kwatra; Kirsty Le Doare; Joy E Lawn
Journal:  Vaccine       Date:  2020-09-02       Impact factor: 3.641

2.  Association of sexually-transmitted infection and African-American race with Streptococcus agalactiae colonization in pregnancy.

Authors:  Gerald A Capraro; Sajel Lala; Khaldia Khaled; Elizabeth Gosciniak; Brianna Saadat; Sarah M Alvarez; Seema Kumar; Tara Calhoun; Edward Landry; Gloria Caldito; Joseph A Bocchini; John A Vanchiere
Journal:  Antimicrob Resist Infect Control       Date:  2020-11-04       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.